Faithward Advisors’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-123,884
| Closed | -$1.27M | – | 326 |
|
|
2022
Q4 | $1.27M | Buy |
123,884
+7,972
| +7% | +$82K | 0.28% | 60 |
|
|
2022
Q3 | $2.11M | Buy |
115,912
+35,769
| +45% | +$651K | 0.5% | 50 |
|
|
2022
Q2 | $4.12M | Buy |
80,143
+62,401
| +352% | +$3.21M | 0.92% | 33 |
|
|
2022
Q1 | $1.31M | Buy |
17,742
+1,977
| +13% | +$146K | 0.25% | 58 |
|
|
2021
Q4 | $2.26M | Sell |
15,765
-2,116
| -12% | -$303K | 0.43% | 50 |
|
|
2021
Q3 | $3.71M | Sell |
17,881
-1,477
| -8% | -$306K | 0.72% | 37 |
|
|
2021
Q2 | $4.11M | Sell |
19,358
-2,905
| -13% | -$617K | 0.81% | 37 |
|
|
2021
Q1 | $4.04M | Buy |
+22,263
| New | +$4.04M | 0.9% | 28 |
|
|
2020
Q4 | – | Sell |
-26,663
| Closed | -$2.89M | – | 190 |
|
|
2020
Q3 | $2.89M | Buy |
+26,663
| New | +$2.89M | 0.7% | 45 |
|